coronavirus vaccine. Moderna, whose covid vaccine is already in final trial, said that that it had already received about $400 million in deposits for potential supply.Moderna's vaccine candidate is one of the few to be in the final stages of testing as drugmakers race to develop a safe and effective covid vaccine.
Last week, Moderna announced the start of a late-stage trial on 30,000 people to demonstrate that its vaccine was safe and effective.The company, which ended the quarter with $3.1 billion in cash, cash equivalents and investments, said it was on track to complete enrollment in the study in September.Moderna has said it plans to price its coronavirus vaccine in a way that ensures broad access. "As we pivot to a commercial stage.